Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features

@article{Beringer2000UnusualRB,
  title={Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features},
  author={Paul M. Beringer and Maria D. Appleman},
  journal={Current Opinion in Pulmonary Medicine},
  year={2000},
  volume={6},
  pages={545-550}
}
Pulmonary infections continue to be a significant source of morbidity and mortality among patients with cystic fibrosis. Although our understanding of the pathogenesis and clinical consequences of pulmonary infections with Pseudomonas aeruginosa has increased greatly in recent years, very little is known about potentially emerging pathogens such as Burkholderia cepacia complex, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and methicillin-resistant Staphylococcus aureus. In this… 
Pneumonia Due to Bordetella bronchiseptica in a Cystic Fibrosis Patient: 16S rRNA Sequencing for Diagnosis Confirmation
ABSTRACT Bordetella bronchiseptica was identified as an unusual etiologic agent of pulmonary recurrent exacerbations and pneumonia in a cystic fibrosis (CF) patient by utilizing a 16S rRNA molecular
Isolation of Infectious Cystic Fibrosis Patients: Results of a Systematic Review
TLDR
A systematic literature review of segregation of CF patients colonized with Burkholderia cepacia species, Pandoraea species, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, or Alcaligenes species found recommendations to be separated from noncolonized patients in single rooms.
Prospective evaluation of emerging bacteria in cystic fibrosis.
TLDR
These data suggest a high variability between centres regarding the prevalence of emerging bacteria, and most patients maintained a stable clinical condition during the 6-month study period despite being colonised with emerging bacteria.
Emerging cystic fibrosis pathogens: incidence and antimicrobial resistance.
We examined the frequency of isolation and the antimicrobial resistance of Burkholderia cepacia complex, Stenotrophomonas maltophilia and Achromobacter xylosoxidans in cystic fibrosis patients from
Spontaneous septic arthritis caused by Burkholderia cepacia.
TLDR
The first reported case of a spontaneous septic arthritis caused by Burkholderia cepacia, the organism responsible for onion skin rot, is described and the difficulty in treating B. cEPacia infections is reviewed.
Update on the epidemiology and management of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, in patients with cystic fibrosis
TLDR
The epidemiology of S. aureus in cystic fibrosis has changed and new treatment/eradication protocols are needed to assess the clinical significance of the increased prevalence of both methicillin-susceptible and methiillin-resistant S.aureus.
Atypical Bacteria in the CF Airways: Diversity, Clinical Consequences, Emergence and Adaptation
TLDR
The inventory of atypical1 bacteria that may be found in the airways of cystic fibrosis patients besides well-known typical CF pathogens has greatly evolved over the past decades.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005.
TLDR
Retrospective analysis of sputum microbiology from adult CF patients using the Royal Brompton Hospital CF database found P. aeruginosa colonisation has remained stable; there has been a decline in B. cepacia complex, H. influenzae and Aspergillus sp.
Epidemiology of Pseudomomas aeruginosa and Achromobacter xylosoxidans in Belgian cystic fibrosis patients, relying on molecular typing techniques
TLDR
It is hypothesized that A.xylosoxidans is a coloniser of more damaged lungs rather than a destructive infectious organism, however it is obvious that more, especially prospective, studies on the clinical relevance of A. xylos Oxidans are needed.
A German external quality survey of diagnostic microbiology of respiratory tract infections in patients with cystic fibrosis.
TLDR
A periodical EQA programme for German CF laboratories and standardized microbiological procedures seem to be necessary to advance diagnostic microbiology employed on CF respiratory tract specimens and may help to improve anti-infective treatment and infection control practices for CF patients.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 33 REFERENCES
Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.
TLDR
Microbiology results from two multicenter, double-blind, placebo-controlled trials of inhaled tobramycin in cystic fibrosis were monitored for longitudinal changes in sputum microbial flora, antibiotic susceptibility, and selection of P. aeruginosa isolates with decreased tobramYcin susceptibility.
Identification of Burkholderia spp. in the Clinical Microbiology Laboratory: Comparison of Conventional and Molecular Methods
TLDR
The PCR-RFLP method appeared to be the optimal method for accurate nucleic acid-mediated identification of the different Burkholderia spp.
Burkholderia cepacia. Management issues and new insights.
  • J. Lipuma
  • Medicine, Biology
    Clinics in chest medicine
  • 1998
TLDR
The current understanding of the epidemiology of B. cepacia infection is reviewed, important recent developments in the microbiology and taxonomy of this species are described, and issues that remain obstacles to defining the optimal management of the disease are presented.
Impact of Microbiology Practice on Cumulative Prevalence of Respiratory Tract Bacteria in Patients with Cystic Fibrosis
TLDR
Differences in the frequency at which specimens for culture were obtained, in the use of selective media for Staphylococcus aureus andHaemophilus influenzae, and in theUse of a prolonged incubation for Burkholderia cepacia contribute to prevalence differences among sites and may result in differences in clinical care.
Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis.
TLDR
Evidence suggests that patient-to-patient transmission of the organism occurred, and supports nosocomial infection in the ward and/or outpatient clinic despite general and stringent infection-control measures.
Four additional cases of Burkholderia gladioli infection with microbiological correlates and review.
TLDR
In vitro laboratory investigations demonstrated that B. gladioli strains were susceptible to complement-mediated lysis of pooled human serum, thus implying that healthy individuals should be immune to infection, suggesting that this species has a low pathogenic potential.
Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit.
TLDR
Policy for limiting CF-patient admission to hospital is supported but transmission of MRSA does not appear to be a reason for limiting social contact with other CF patients.
Epidemiological investigation of infections due to Alcaligenes species in children and patients with cystic fibrosis: use of repetitive-element-sequence polymerase chain reaction.
  • W. Dunne, S. Maisch
  • Biology, Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1995
TLDR
It is concluded that, similar to Pseudomonas aeruginosa, Alcaligenes species (most often A. xylosoxidans) colonize the respiratory tract of intubated children and of patients with CF.
Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.
TLDR
B cepacia appears to be linked to the decline in colonised individuals and confers a worse prognosis than Pseudomonas aeruginosa alone, which is linked to an increase in the numbers of transplants and deaths amongst the cases.
Infections in patients with cystic fibrosis following lung transplantation.
TLDR
The findings suggest that lung transplantation should be considered in CF patients infected with multidrug-resistant organisms, and the organisms present before transplantation were not the primary cause of mortality in this patient population.
...
1
2
3
4
...